219 related articles for article (PubMed ID: 19150875)
1. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
Mayer SA; Davis SM; Skolnick BE; Brun NC; Begtrup K; Broderick JP; Diringer MN; Steiner T;
Stroke; 2009 Mar; 40(3):833-40. PubMed ID: 19150875
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
[TBL] [Abstract][Full Text] [Related]
4. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII for acute intracerebral hemorrhage.
Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
Mayer SA; Brun NC; Broderick J; Davis SM; Diringer MN; Skolnick BE; Steiner T;
Neurocrit Care; 2006; 4(3):206-14. PubMed ID: 16757825
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
[TBL] [Abstract][Full Text] [Related]
10. Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial.
Al-Ajlan FS; Gladstone DJ; Song D; Thorpe KE; Swartz RH; Butcher KS; Del Campo M; Dowlatshahi D; Gensicke H; Lee GJ; Flaherty ML; Hill MD; Aviv RI; Demchuk AM;
Stroke; 2023 Mar; 54(3):715-721. PubMed ID: 36756899
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral hemorrhage: outcomes and eligibility for factor VIIa treatment in a National Stroke Registry.
Nadeau JO; Phillips S; Shi HS; Kapral MK; Gladstone DJ; Silver FL; Hill MD;
Cerebrovasc Dis; 2006; 22(4):271-5. PubMed ID: 16788301
[TBL] [Abstract][Full Text] [Related]
12. Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
Mayer SA; Rincon F
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S70-6. PubMed ID: 16427389
[TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of ICH enlargement.
Wartenberg KE; Mayer SA
J Neurol Sci; 2007 Oct; 261(1-2):99-107. PubMed ID: 17631908
[TBL] [Abstract][Full Text] [Related]
14. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Selin S; Tejani A
Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
[TBL] [Abstract][Full Text] [Related]
16. Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
Diringer MN; Ferran JM; Broderick J; Davis S; Mayer SA; Steiner T; Brun NC; Skolnick BE; Christensen MC
Cerebrovasc Dis; 2007; 24(2-3):219-25. PubMed ID: 17630481
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage.
Earnshaw SR; Joshi AV; Wilson MR; Rosand J
Stroke; 2006 Nov; 37(11):2751-8. PubMed ID: 17008607
[TBL] [Abstract][Full Text] [Related]
18. Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).
Steiner T; Vincent C; Morris S; Davis S; Vallejo-Torres L; Christensen MC
J Stroke Cerebrovasc Dis; 2011; 20(4):287-94. PubMed ID: 20452785
[TBL] [Abstract][Full Text] [Related]
19. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
Mayer SA
Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
[TBL] [Abstract][Full Text] [Related]
20. Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.
Al-Shahi Salman R
Cochrane Database Syst Rev; 2009 Oct; (4):CD005951. PubMed ID: 19821350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
